These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15867600)

  • 1. The early work on hormonal contraceptive use and HIV acquisition.
    Martin HL; Richardson BA; Mandaliya K; Achola JO; Overbaugh J; Kreiss JK
    J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S12-4. PubMed ID: 15867600
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort.
    Baeten JM; Lavreys L; Sagar M; Kreiss JK; Richardson BA; Chohan B; Panteleeff D; Mandaliya K; Ndinya-Achola JO; Overbaugh J; Farley T; Mwachari C; Cohen C; Chipato T; Jaisamrarn U; Kiriwat O; Duerr A
    J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S18-21. PubMed ID: 15867603
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective clinical trials designed to assess the use of hormonal contraceptives and risk of HIV acquisition.
    Morrison CS; Richardson BA; Celentano DD; Chipato T; Mmiro F; Mugerwa R; Padian NS; Rugpao S; Salata RA
    J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S17-8. PubMed ID: 15867602
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women.
    Baeten JM; Benki S; Chohan V; Lavreys L; McClelland RS; Mandaliya K; Ndinya-Achola JO; Jaoko W; Overbaugh J
    AIDS; 2007 Aug; 21(13):1771-7. PubMed ID: 17690576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate.
    Hapgood JP
    Endocrinology; 2013 Mar; 154(3):985-8. PubMed ID: 23429710
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormonal contraception and HIV risk: evaluating marginal-structural-model assumptions.
    Chen PL; Cole SR; Morrison CS
    Epidemiology; 2011 Nov; 22(6):877-8. PubMed ID: 21968782
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormonal contraception and HIV acquisition risk: implications for individual users and public policies.
    Jain AK
    Contraception; 2012 Dec; 86(6):645-52. PubMed ID: 22541635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestin-based contraception regimens modulate expression of putative HIV risk factors in the vaginal epithelium of pig-tailed Macaques.
    Bosinger SE; Tharp GK; Patel NB; Zhao C; Payne TL; Dietz Ostergaard S; Butler K; Ellis S; Johnson RL; Kersh EN; McNicholl JM; Vishwanathan SA
    Am J Reprod Immunol; 2018 Oct; 80(4):e13029. PubMed ID: 30076667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection.
    Boodhram R; Moodley D; Abbai N; Ramjee G
    BMC Womens Health; 2019 May; 19(1):63. PubMed ID: 31068152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.
    Baeten JM; Nyange PM; Richardson BA; Lavreys L; Chohan B; Martin HL; Mandaliya K; Ndinya-Achola JO; Bwayo JJ; Kreiss JK
    Am J Obstet Gynecol; 2001 Aug; 185(2):380-5. PubMed ID: 11518896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study.
    Lavreys L; Baeten JM; Martin HL; Overbaugh J; Mandaliya K; Ndinya-Achola J; Kreiss JK
    AIDS; 2004 Mar; 18(4):695-7. PubMed ID: 15090778
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1.
    Martin HL; Nyange PM; Richardson BA; Lavreys L; Mandaliya K; Jackson DJ; Ndinya-Achola JO; Kreiss J
    J Infect Dis; 1998 Oct; 178(4):1053-9. PubMed ID: 9806034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.
    Hapgood JP; Kaushic C; Hel Z
    Endocr Rev; 2018 Feb; 39(1):36-78. PubMed ID: 29309550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on "hormonal contraception and HIV prevalence in four African countries".
    Gisselquist D
    Contraception; 2008 Oct; 78(4):346; author reply 346-7. PubMed ID: 18847587
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies.
    Ralph LJ; McCoy SI; Shiu K; Padian NS
    Lancet Infect Dis; 2015 Feb; 15(2):181-9. PubMed ID: 25578825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women.
    Richardson BA; Otieno PA; Mbori-Ngacha D; Overbaugh J; Farquhar C; John-Stewart GC
    AIDS; 2007 Mar; 21(6):749-53. PubMed ID: 17413696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End of the debate on hormonal contraception and HIV risk?
    Lancet Infect Dis; 2015 Feb; 15(2):131. PubMed ID: 25749056
    [No Abstract]   [Full Text] [Related]  

  • 19. Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?
    Polis CB; Achilles SL; Hel Z; Hapgood JP
    Contraception; 2018 Mar; 97(3):191-197. PubMed ID: 29242082
    [No Abstract]   [Full Text] [Related]  

  • 20. Broadening the debate over HIV and hormonal contraception.
    Colvin CJ; Harrison A
    Lancet Infect Dis; 2015 Feb; 15(2):135-6. PubMed ID: 25578824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.